Market Place
Sourcing Support
Codagenix Receives Additional Award from US Department of Defense
24 Oct 2023 //
PR NEWSWIRE
Codagenix Announces Presentation of Positive Clinical Immunogenicity Data
11 Oct 2023 //
PR NEWSWIRE
Codagenix initiates new study of live-attenuated vaccine in RSV
11 May 2023 //
CLINICAL TRIALS ARENA
Codagenix Initiates Dosing in Ph 1 Study of Intranasal, Live RSV Vaccine
10 May 2023 //
PR NEWSWIRE
Codagenix Announces Appointment of Kimber Poffenberger as CSO
28 Mar 2023 //
PR NEWSWIRE
Codagenix Announces Close of $25 million Extension of Series B
15 Feb 2023 //
PR NEWSWIRE
ImmunityBio, Codagenix and EuMentis raise funds, while a biotech SPAC dissolves
15 Feb 2023 //
ENDPTS
Codagenix Receives FDA Fast Track Designation for RSV Vaccine Candidate
02 Nov 2022 //
PRNEWSWIRE
Codagenix and SII begin subject dosing in Phase III Covid-19 vaccine trial
27 Oct 2022 //
CLINICALTRIALSARENA
Codagenix Initiates Dosing in Phase 3 Trial of Intranasal COVID-19 Vaccine
26 Oct 2022 //
PRNEWSWIRE
Codagenix Completes Dosing in Phase 1 Trial of Universal Influenza Vaccine
14 Jun 2022 //
PRNEWSWIRE
FDA Clears Codagenix`s IND for Live-Attenuated, Intranasal RSV Vaccine
01 Jun 2022 //
PRNEWSWIRE
Codagenix doses first subject in Phase I intranasal Covid-19 vaccine trial
26 May 2022 //
CLINICALTRIALSARENA
Codagenix Initiates PI Evaluation of Intranasal Vaccine CoviLiv
25 May 2022 //
PRNEWSWIRE
Codagenix to Present Promising Preclinical Data for Oncolytic Virus Therapeutic
09 Nov 2021 //
PRNEWSWIRE
Codagenix Presents +ve Phase 1 Data for COVI-VAC Intranasal COVID-19 Vaccine
30 Sep 2021 //
APNEWS
Codagenix Announces Positive Data from Phase 1 COVID-19 Intranasal Vaccine Trial
22 Sep 2021 //
PRNEWSWIRE
Intranasal COVID-19 vaccine demonstrates single-dose efficacy
30 Jun 2021 //
PR NEWSWIRE
Codagenix Appoints Linda Maldonado as VP, Biologics Chemistry and Manufacturing
14 Apr 2021 //
PRNESWIRE
Codagenix`s CEO to Present Update on COVI-VAC During New York Academy
01 Feb 2021 //
PRNEWSWIRE
Codagenix Secures U.S. Patent for Codon-Deoptimized RSV Vaccine Candidates
26 Jan 2021 //
PRNEWSWIRE
Codagenix and SII begin dosing in Phase I Covid-19 vaccine trial
12 Jan 2021 //
PHARMACEUTICAL-TECHNOLOGY
Codagenix & Serum Institute of India Initiate Dosing in Pha1 Trial of COVI-VAC
11 Jan 2021 //
PRNEWSWIRE
Codagenix, SII begin dosing in Phase I Covid-19 vaccine trial
11 Jan 2021 //
PHARMACEUTICAL-TECHNOLOGY
Codagenix, Serum Institute take nasal COVID-19 vaccine into clinic
22 Dec 2020 //
FIERCE PHARMA
Green light for UK trial of nasal coronavirus vaccine
15 Dec 2020 //
PHARMATIMES
Codagenix and Serum Institute of India Announce of First-in-Human Trial
14 Dec 2020 //
PRNEWSWIRE
Codagenix, Serum Institute to begin UK trials of nasal COVID-19 vaccine in Jan
14 Dec 2020 //
REUTERS
Codagenix Inc. Completes Dosing for Phase 1 Trial of Live-Attenuated
01 Dec 2020 //
PRNEWSWIRE
SII Initiates Manufacturing of Codagenix`s Intranasal COVID-19 Vaccine
22 Sep 2020 //
BIOSPACE
